The Diagnostic Imaging CT modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of CT across the healthcare continuum, from various cancer screenings, such as lung and colon, to cardiothoracic imaging, to appendicitis, and more.
October 29th 2024
The AI-enabled AutoChamber software also garnered the FDA’s breakthrough device designation for opportunistic detection of enlarged heart chambers on non-contrast CT scans.
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
Canadian reactor ramps up to renew supply of technetium
January 3rd 2008The Canadian nuclear reactor critical to the supply of technetium (Tc-99m) in the U.S. has restarted, but the raw material that MDS Nordion processes into the medical isotope needed for nuclear medicine studies will not be in full production until the end of this week.
CT vendors vie for leadership with emerging technologies
January 3rd 2008An hour after the RSNA show floor opened, employees of Philips Medical Systems lifted the earth-toned drape that obscured the company’s answer to Toshiba’s flat-panel CT. The 256-slice system was as much a surprise as Toshiba’s 320-element system, as each company exceeded expectations in an industry marked this year by superlatives.
Toshiba displays first flat-panel CT system
January 3rd 2008The first in a new generation of CT scanners will be on the market in summer 2008. Aquilion One from Toshiba America Medical Systems debuted at RSNA accompanied by dynamic studies of the brain and heart that demonstrated unprecedented clinical results. Preliminary results indicate that the system can detect subtle changes in blood flow or blockages as small as 1.5 mm in diameter.
Trouble-prone Chalk River haunts medical community: When will we learn?
January 3rd 2008Fifteen years ago, a strike at the Chalk River Laboratories nuclear reactor in Ottawa, the main source of raw material for technetium-99m, was averted hours before the walkout was to take effect. Three years later, in 1995, a fuel rod got stuck. Fortunately, repairs caused only a four-day shutdown.
Siemens’ Definition AS redefines CT
December 20th 2007Siemens Medical Solutions unveils a new CT platform this week at the RSNA meeting that company executives claim will put an end to the slice wars vendors have been fighting since the first multislice scanners were commercialized eight years ago.
CTA and stress perfusion imaging play complementary roles in the diagnosis of ischemic heart disease
December 18th 2007Research studies published in November and December demonstrate there are no one-stop radiologic shops for the diagnosis of cardiovascular disease. Each modality is endowed with specific strengths that recommend it as the instrument of choice in specific clinical situations.
Trouble-prone Chalk River haunts medical community: When will we learn?
December 17th 2007Fifteen years ago, a strike at the Chalk River Laboratories nuclear reactor in Ottawa, the main source of raw material for technetium-99m, was averted hours before the walkout was to take effect. Three years later, in 1995, a fuel rod got stuck. Fortunately, repairs caused only a four-day shutdown.
Microsphere management of liver mets gains strength
December 1st 2007Radioactive microsphere therapy is gaining in popularity among specialists who deal with both primary and metastatic solid tumors in the liver. During the past two years, sessions dedicated to this therapeutic approach have been held in meetings of all major related specialties: interventional radiology, radiology, radiation oncology, surgical oncology, hepatobiliary surgery, nuclear medicine, and medical oncology.
Italian university honors Penn nuclear physician
December 1st 2007Dr. Abass Alavi, a professor of radiology at the University of Pennsylvania, is the first nuclear medicine physician to receive the University of Bologna's prestigious laurea honoris causa. Alavi received the honorary doctorate in medicine and surgery for his contribution to the development of the radiotracer FDG.
Demand numbers for nuclear medicine show drop in 2006
December 1st 2007As sure as the sun fades in the west, reimbursements for medical imaging set over time, a natural consequence of familiarity and increased demand, followed inevitably by increased productivity. But in 2006, the expected increase in demand did not happen in nuclear medicine.